# RANOLAZINE

NDC: 68180-355
Generic name: RANOLAZINE
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190227

FDA application: ANDA201046

## Active ingredients

- RANOLAZINE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68180-355"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68180-355
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595821d7-1fbf-49a5-9c62-d78f27af39b4